Immune Checkpoint Inhibitor–Induced Vitiligo-Like Depigmentation

This retrospective case series compares vitiligo resulting from immune checkpoint inhibitor (ICI) therapy vs preexisting vitiligo among patients receiving ICI treatment for cancer.

Authors

Institutions

Publication Details

Journal
JAMA Dermatology
Published
2024-12-23
DOI
https://doi.org/10.1001/jamadermatol.2024.5136
Citations
8
Primary Topic
Melanoma and MAPK Pathways
Type
article
Field-Weighted Citation Impact
1.87
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immune Checkpoint Inhibitor–Induced Vitiligo-Like Depigmentation

Azael Freites‐Martínez, Luca Rapparini, Emily Avitan‐Hersh, Vasiliki A. Nikolaou et al.
8 citations
JAMA Dermatology
Melanoma and MAPK Pathways
1.87
article

Immune Checkpoint Inhibitor–Induced Vitiligo-Like Depigmentation

Azael Freites‐Martínez, Luca Rapparini, Emily Avitan‐Hersh, Vasiliki A. Nikolaou, Zsuzsanna Lengyel, Priscila Giavedoni, Lukas Kraehenbuehl, Bianca Maria Piraccini, Dimitra Koumaki, F. Dezoteux, Stephano Cedirian, Pietro Sollena, Davide Fattore, Aram Boada, Yannick S. Elshot, Ernesto Rossi, L. Peuvrel, Sònia Segura, Julia Riganti, Tatjana Radević, Mariana Lopez Leon, V. Sibaud, Zoé Apalla, Michela Valeria Rita Starace, Ana‐Maria Forsea, Ketty Peris, Alessandro Pileri, C. Carrera, Chryssoula Papegeorgiou, Nada Saffuri
article en
8 citations

Abstract

This retrospective case series compares vitiligo resulting from immune checkpoint inhibitor (ICI) therapy vs preexisting vitiligo among patients receiving ICI treatment for cancer.

JAMA DermatologyVol. 161(2)
Military Medical Academy (RS), Inserm (FR), Carol Davila University of Medicine and Pharmacy (RO), Technion – Israel Institute of Technology (IL), National and Kapodistrian University of Athens (GR), University of Zurich (CH), Aristotle University of Thessaloniki (GR), Université de Lille (FR), Rambam Health Care Campus (IL), Instituto de Salud Carlos III (ES), Hospital Italiano de Buenos Aires (AR), Agostino Gemelli University Polyclinic (IT), The Netherlands Cancer Institute (NL), Centre Hospitalier Universitaire de Lille (FR), IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT), Institut universitaire du cancer de Toulouse Oncopole (FR), University Hospital of Zurich (CH), Institut de Cancérologie de l'Ouest (FR), Centre for Biomedical Network Research on Rare Diseases (ES), Hospital Clínic de Barcelona (ES), Andreas Sygros Hospital (GR), Lille Inflammation Research International Center (FR), Parc de Salut (ES), University Hospital of Heraklion (GR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Hospital Universitari Germans Trias i Pujol (ES), Hospital del Mar Research Institute (ES), Instituto de Investigación de Enfermedades Raras (ES), University of Naples Federico II (IT), Universitat de Barcelona (ES), University of Pecs (HU), University of Amsterdam (NL), Universidad Europea de Madrid (ES), University of Bologna (IT)
Good health and well-being
Openalex Percentile: Top 14%
Melanoma and MAPK Pathways
1.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.